FLINT
-
WI Bureau Sep 29 2017 - 1 min readA clinical trial in the US has received an experimental drug that aimed at treating a common liver disease with promising results. As per a report of leading business daily, The Economic Times, people with non-alcoholic steatohepatitis (NASH) who took obeticholic acid (OCA) had felt improved liver health during that duration, which also ...